LiverRight and Aegle Medical Solutions, LLC have announced a strategic partnership aimed at expanding access to non-invasive liver assessment, specialist interpretation, diagnosis, and ongoing liver care for patients across the United States. The collaboration brings together Aegle Medical's advanced liver assessment technology and support services with LiverRight's national virtual liver clinic, creating a more connected pathway for healthcare organizations to move patients efficiently from liver disease identification to specialist interpretation, diagnosis, and longitudinal management.
For physicians, health systems, and independent practices, the partnership is designed to simplify the establishment or expansion of comprehensive liver disease programs without having to build every component internally. Aegle Medical provides a consultative approach to technology evaluation, implementation, training, and ongoing support, including the Mindray Hepatus-Series Transient Elastography Diagnostic Ultrasound Systems. LiverRight complements this with same-day interpretation services for liver elastography studies and same-week virtual access to its hepatology clinicians. LiverRight's Liververse™ referral system further supports the care pathway by coordinating bloodwork, patient-reported outcomes, available imaging, diagnosis, and longitudinal disease management.
The implications of this partnership are significant for addressing the large number of adults living with undiagnosed liver disease in the United States. By bringing advanced liver assessment into the outpatient setting and providing timely specialist interpretation, the collaboration aims to identify liver disease earlier, improve access to specialist expertise, and create a better experience for both patients and clinicians. This is particularly valuable in communities where access to hepatology specialists may be limited, as it allows patients to receive advanced assessment closer to where they already receive care.
Central to the partnership is the Mindray Hepatus platform, which represents a next-generation approach to non-invasive liver assessment. The Hepatus introduces Visualized Transient Elastography (ViTE), a breakthrough that integrates real-time B-mode ultrasound visualization directly into the elastography examination. Unlike conventional transient elastography platforms that rely primarily on measurement data without real-time anatomical visualization, ViTE enables operators to see the liver anatomy, identify the optimal measurement location, and visually guide each acquisition while simultaneously obtaining quantitative liver stiffness and attenuation measurements. This evolution from conventional transient elastography to B-mode image-guided ViTE combines the efficiency of transient elastography with the clinical confidence of real-time ultrasound visualization in a single examination.
The Hepatus platform provides liver stiffness measurement (LSM) for fibrosis assessment and Liver UltraSound Attenuation (LiSA) for quantitative assessment of hepatic steatosis. The Hepatus 6 further expands the platform beyond liver elastography by combining these capabilities with diagnostic ultrasound imaging, allowing clinicians to utilize the system for abdominal imaging, Doppler, spleen stiffness assessment, and intestinal ultrasound depending on configuration. This versatility supports a broader range of hepatology and gastroenterology applications, offering healthcare organizations an opportunity to modernize liver assessment while improving workflow efficiency and expanding the clinical utility of their investment.
LiverRight has its own hepatologists and hepatology advanced practice providers licensed across all 50 U.S. states. Its clinicians support adult patients with liver conditions including MASLD/MASH, alcohol-associated liver disease, hepatitis B and C, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, and liver cancer diagnosis. The strategic relationship gives health systems, GI and hepatology practices, and independent providers a scalable approach to expanding liver services by combining access to advanced non-invasive liver assessment technology, implementation and clinical support, timely specialist interpretation, and a pathway to continued liver care—all under the provider's brand.
Brandon Tudor, CEO of LiverRight, noted that the partnership helps practices bring advanced liver assessment into the outpatient setting, provide timely specialist interpretation, and move patients into the appropriate diagnostic and care workflow with greater efficiency. Michael McTighe, President & CEO of Aegle Medical Solutions, added that the model can be particularly valuable for communities with limited access to hepatology specialists, with the goal of helping providers identify liver disease earlier and improve access to specialist expertise.
